Active Ingredient: RANOLAZINE
Proprietary Name: RANEXA
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 500MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021526
Product Number: 002
Approval Date: Jan 27, 2006
Applicant Holder Full Name: MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG SA
Marketing Status:
Discontinued
Patent and Exclusivity Information
